BEIJING: The insulin glargine injections developed by a Chinese pharmaceutical company has been approved for diabetes patients in Pakistan. The insulin glargine injecta BASAGINE developed received ...
The insulin glargine injecta BASAGINE developed by a Chinese pharmaceutical company has received approval for registration by the Drug Regulatory Authority of Pakistan (DRAP), China Economic Net (CEN) ...
BEIJING, Jan. 13 (China Economic Net)-Recently, the insulin glargine injecta BASAGINE developed by a Chinese pharmaceutical company received approval for registration (Reg. No. 111178) by the Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results